Genomics

Dataset Information

31

An EphB-Abl signaling pathway important for intestinal tumor initiation and growth


ABSTRACT: EphB receptors regulate the proliferation and positioning of intestinal stem and progenitor cells. In addition, they can act as tumor promoters for adenoma development, but suppress progression to invasive carcinoma. Here we used imatinib to abrogate Abl kinase activity in ApcMin/+ mice and in mice with LGR5+ stem cells genetically targeted for APC. This treatment inhibited the tumor-promoting effects of EphB signaling without attenuating EphB-mediated tumor suppression, demonstrating the role of EphB signaling in intestinal tumor initiation. The investigated treatment regimen extended the lifespan of ApcMin/+ mice, and reduced cell proliferation in cultured slices of adenomas from FAP patients. These findings connect the EphB signaling pathway to the regulation of intestinal adenoma initiation via Abl kinase. Our findings may have clinical implications for pharmacological therapy against adenoma formation and cancer progression in patients predisposed to develop colon cancer. We used microarray to assess the short term (3h and 12h) effects on gene expression in colon stem and progenitor cells after administration of Imatinib. Overall design: Colon samples were obtained at different timepoints after injection of Imatinib and processes for RNA extraction and hybridization for Affymetrix array.

INSTRUMENT(S): [Mouse430_2] Affymetrix Mouse Genome 430 2.0 Array

SUBMITTER: Maria Genander 

PROVIDER: GSE63188 | GEO | 2014-11-13

SECONDARY ACCESSION(S): PRJNA266928

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
GSE63188_RAW.tar Raw
filelist.txt Txt
Items per page:
1 - 2 of 2
altmetric image

Publications

An EphB-Abl signaling pathway is associated with intestinal tumor initiation and growth.

Kundu Parag P   Genander Maria M   Strååt Klas K   Classon Johanna J   Ridgway Rachel A RA   Tan Ee Hong EH   Björk Jan J   Martling Anna A   van Es Johan J   Sansom Owen J OJ   Clevers Hans H   Pettersson Sven S   Frisén Jonas J  

Science translational medicine 20150401 281


EphB receptors regulate the proliferation and positioning of intestinal stem and progenitor cells. In addition, they can act as tumor promoters for adenoma development but suppress progression to invasive carcinoma. We used imatinib to abrogate Abl kinase activity in Apc(Min/+) mice and in mice with LGR5(+) stem cells that were genetically engineered to develop adenomatous polyposis coli. Imatinib treatment inhibited the tumor-promoting effects of EphB signaling without attenuating EphB-mediated  ...[more]

Similar Datasets

2018-01-01 | S-EPMC6120921 | BioStudies
2015-04-29 | E-GEOD-68334 | ArrayExpress
2009-01-01 | S-EPMC2786256 | BioStudies
2018-01-01 | S-EPMC6068201 | BioStudies
2018-01-01 | S-EPMC6314334 | BioStudies
2021-01-01 | S-EPMC7836395 | BioStudies
2020-01-01 | S-EPMC7083897 | BioStudies
2020-01-01 | S-EPMC6933338 | BioStudies
2018-01-01 | S-EPMC6126694 | BioStudies
1000-01-01 | S-EPMC2084320 | BioStudies